West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors
This was the stock’s second consecutive day of losses.
Uncategorized
EU announces $44.4M in funding for Rwanda’s pharmaceutical sector
Funded projects will support Rwanda’s vision of becoming regional hub for pharmaceutical and biotechnology industry, says official – Anadolu Ajansı
BioMarin Pharmaceutical: A Volatile But Growing Trajectory
BioMarin Pharmaceutical Inc.’s stagnant shares present a compelling investment opportunity amid uncertainty in the biotechnology industry. Click for my BMRN update.
Pharmaceutical Drug Delivery Market to Hit USD 2,546 Billion by 2029 | MarketsandMarkets™
The global pharmaceutical drug delivery market is set to grow from USD 1,949.4 billion in 2024 to USD 2,546.0 billion by 2029, with a CAGR of 5.5%. This growth is driven by increasing chronic disease prevalence,
BioMarin Pharmaceutical (BMRN) Gets a Hold from Scotiabank
In a report released today, George Farmer from Scotiabank maintained a Hold rating on BioMarin Pharmaceutical (BMRN – Research Report),
Opioid maker Purdue Pharma’s global counterparts make millions overseas
A first-of-its-kind analysis conducted as part of an investigation by journalists in eight countries found that some of the same tactics used to persuade a generation of U.S. doctors that potent painkillers could be safely prescribed have been used abroad.
Sun Pharmaceutical Industries rises Tuesday, outperforms market
Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.16% to 1,865.90 Indian rupees Tuesday, on what proved to be an all-around great trading session for the stock market, with the BSE SENSEX Index 1 rising 0.
Zydus Lifesciences To Acquire Sterling Biotech’s Active Pharmaceutical Ingredients Business
Zydus Lifesciences is one of the biggest names in the pharma business of the country. In a recent development, the company has announced of a crucial acquisition deal. The company announced the 50 per cent acquisition of Mumbai-based Sterling Biotech Ltd.
Buy Rating on BioMarin Pharmaceutical with Strong Value Proposition Despite Competition
Analyst Mohit Bansal of Wells Fargo maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), reducing the price
Sun Pharmaceutical Industries outperforms market on strong trading day
Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.49% to 1,862.95 Indian rupees Monday, on what proved to be an all-around positive trading session for the stock market, with the BSE SENSEX Index 1 rising 0.